Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a Finger-Worn gadget diagnose sleep apnea?

NCT ID NCT07485582

Diagnosis Sponsor: ResMed Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Aug 20, 2026 · Updated 3 times

Summary

This study will test several new wearable devices and a mobile app to see how well they diagnose obstructive sleep apnea (OSA) compared to the standard overnight sleep test. About 90 adults will wear devices like a finger sensor, wristband, ring, patches, and an eye mask while also undergoing the gold-standard test. The goal is to find accurate, easy-to-use home diagnostic tools.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, these devices could offer more convenient and accessible ways to diagnose sleep apnea at home.
What could go wrong
This is an early-stage device comparison study, not a treatment trial. The new devices may not be as accurate as the gold standard test.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient suspected or known to have OSA

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participant is 18 years of age or older * Participant is willing to provide informed consent * Participant is willing to participate in all study related procedures Exclusion Criteria: * Unable to cease PAP therapy during PSG (if currently using) * Requires use of oxygen therapy during sleep * Diagnosis of untreated clinically relevant sleep disorder (other than SDB, e.g. severe insomnia) * Who are or may be pregnant * Participants are unsuitable to participate in the study in the opinion of the investigator * Participant has a permanent pacemaker, sustained non-sinus cardiac arrhythmias, and/or takes alpha blocker or short acting nitrate medication. * Shift workers who worked an overnight shift in the past 3 days * Participant who are contraindicated to use the NightOwl sensor

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obstructive sleep apnea are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obstructive sleep apnea

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Adelaide Institute for Sleep Health (FHMRI Sleep Health), Flinders University

    Adelaide, South Australia, Australia

  • Centre for Sleep Science, The University of Western Australia.

    Perth, UWA, Australia

  • Flinders Health and Medical Research Institute

    Adelaide, South Australia, Australia

  • Queen Elizabeth hosptial respiratory and sleep unit

    Woodville South, South Australia, Australia

  • Victorian Respiratory Support Service (VRSS)

    Heidelberg, Victoria, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.